Quest Diagnostics Incorporated (DGX)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Quest Diagnostics Incorporated (DGX) is up 14.7% since the beginning of the year. At $197 per share, DGX is trading 7.6% below its 52-week high of $214. Investors who bought $1,000 worth of DGX shares 5 years ago would now be looking at an investment worth $1,683.

Quest Diagnostics Incorporated (DGX) has returned 14.65% so far this year and 11.69% over the past 12 months. Over the last ten years, DGX has returned 11.79% per year, falling short of the S&P 500 Index benchmark, which averaged 13.71% annually.

Based on dividend-adjusted daily data since Dec 26, 1996, DGX's average daily return is +0.07%, while the average monthly return is +1.55%. At this rate, an investment would double in approximately 3.8 years.

Historically, 59% of months were positive and 41% were negative. The best month was Apr 2000 with a return of +46.4%, while the worst month was Jul 2002 at -29.8%. The longest winning streak lasted 11 consecutive months, and the longest losing streak was 5 months.

On a daily basis, DGX closed higher 51% of trading days. The best single day was Jul 11, 2000 with a return of +14.8%, while the worst single day was Jan 4, 2001 at -18.3%.

Quest Diagnostics Incorporated has an annualized alpha of 13.83%, beta of 0.62, and R2 of 0.16 versus S&P 500 Index. Calculated based on daily prices since December 26, 1996.

• This stock participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (73.26%) than losses (32.73%) - typical of diversified or defensive assets.
• Beta of 0.62 may look defensive, but with R2 of 0.16 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R2 of 0.16 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

DGX ranks 59 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.

Quest Diagnostics Incorporated provided a 1.65% dividend yield over the last twelve months, with an annual payout of $3.26 per share. The company has been increasing its dividends for 21 consecutive years.

The table displays the monthly dividend distributions for Quest Diagnostics Incorporated. The dividends shown in the table have been adjusted to account for any splits that may have occurred.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Quest Diagnostics Incorporated. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Quest Diagnostics Incorporated was 49.46%, occurring on Feb 14, 2003. Recovery took 452 trading sessions.

The current Quest Diagnostics Incorporated drawdown is 6.55%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Quest Diagnostics Incorporated over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Quest Diagnostics Incorporated is priced in the market compared to other companies in the Diagnostics & Research industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.